CARM earnings: a negative outcome, -7.9%

On April 1, 2024, Carisma Therapeutics Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.9% in the window around the event. It had already run -12.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.